Yong-Sheng Li (Yongsheng Li)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Ejection Fraction

Patient Reported

Top Venues

British journal of cancer

Nature communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yuechen Liu, Zhenkang Li, Jinchao Zhang, Wei Liu, Shenyuan Guan, Yizhi Zhan, Yuan Fang, Yong-Sheng Li, Haijun Deng, Zhiyong Shen
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity. British journal of cancer 131 (2) (2024)
Yong-Sheng Li, Zhiyong Shen, Zhen Chai, Yizhi Zhan, Yaowei Zhang, Zhengyu Liu, Yuechen Liu, Zhenkang Li, Mingdao Lin, Zhanqiao Zhang, Wei Liu, Shenyuan Guan, Jinchao Zhang, Junying Qian, Yi Ding, Guoxin Li, Yuan Fang, Haijun Deng
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity. Gut (2023)
Zhiyong Shen, Yong-Sheng Li, Yuan Fang, Mingdao Lin, Xiaochuang Feng, Zhenkang Li, Yizhi Zhan, Yuechen Liu, Tingyu Mou, Xiaoliang Lan, Yanan Wang, Guoxin Li, Jiping Wang, Haijun Deng
SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development. Molecular oncology 14 (2) (2020)
Yuan Fang, Zhi-Yong Shen, Yi-Zhi Zhan, Xiao-Chuang Feng, Ke-Li Chen, Yong-Sheng Li, Hai-Jun Deng, Su-Ming Pan, De-Hua Wu, Yi Ding
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. Nature communications 10 (1) (2019)